$JRSS
JRSIS HEALTH CARE Corp

2016 Q2 Form 10-Q Financial Statement

#000114420417042622 Filed on August 14, 2017

View on sec.gov

Income Statement

Concept 2016 Q2
Revenue $4.290M
YoY Change 58.23%
Cost Of Revenue $1.110M
YoY Change 42.55%
Gross Profit $3.190M
YoY Change 65.07%
Gross Profit Margin 74.36%
Selling, General & Admin $840.0K
YoY Change 52.73%
% of Gross Profit 26.33%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $260.0K
YoY Change 23.81%
% of Gross Profit 8.15%
Operating Expenses $1.680M
YoY Change 52.73%
Operating Profit $1.510M
YoY Change 81.38%
Interest Expense -$350.0K
YoY Change 16.67%
% of Operating Profit -23.18%
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $1.150M
YoY Change 116.98%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $790.0K
YoY Change 119.44%
Net Earnings / Revenue 18.41%
Basic Earnings Per Share
Diluted Earnings Per Share $47.31K
COMMON SHARES
Basic Shares Outstanding 13.92M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $850.0K
YoY Change 70.0%
Cash & Equivalents $854.5K
Short-Term Investments
Other Short-Term Assets $1.290M
YoY Change 214.63%
Inventory $610.0K
Prepaid Expenses
Receivables $2.320M
Other Receivables $1.060M
Total Short-Term Assets $6.130M
YoY Change 112.12%
LONG-TERM ASSETS
Property, Plant & Equipment $23.14M
YoY Change 0.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.090M
YoY Change 15.96%
Total Long-Term Assets $24.24M
YoY Change 1.33%
TOTAL ASSETS
Total Short-Term Assets $6.130M
Total Long-Term Assets $24.24M
Total Assets $30.37M
YoY Change 13.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $320.0K
YoY Change 21.06%
Accrued Expenses $50.00K
YoY Change 25.0%
Deferred Revenue
YoY Change
Short-Term Debt $760.0K
YoY Change 60.09%
Long-Term Debt Due $1.190M
YoY Change -20.13%
Total Short-Term Liabilities $2.350M
YoY Change -0.89%
LONG-TERM LIABILITIES
Long-Term Debt $17.72M
YoY Change -2.8%
Other Long-Term Liabilities $610.0K
YoY Change
Total Long-Term Liabilities $18.33M
YoY Change 0.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.350M
Total Long-Term Liabilities $18.33M
Total Liabilities $25.11M
YoY Change 21.89%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.250M
YoY Change
Total Liabilities & Shareholders Equity $30.37M
YoY Change 13.27%

Cashflow Statement

Concept 2016 Q2
OPERATING ACTIVITIES
Net Income $790.0K
YoY Change 119.44%
Depreciation, Depletion And Amortization $260.0K
YoY Change 23.81%
Cash From Operating Activities $2.070M
YoY Change 840.91%
INVESTING ACTIVITIES
Capital Expenditures -$1.690M
YoY Change 28.03%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$1.690M
YoY Change 29.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 60.00K
YoY Change -94.59%
NET CHANGE
Cash From Operating Activities 2.070M
Cash From Investing Activities -1.690M
Cash From Financing Activities 60.00K
Net Change In Cash 440.0K
YoY Change 2100.0%
FREE CASH FLOW
Cash From Operating Activities $2.070M
Capital Expenditures -$1.690M
Free Cash Flow $3.760M
YoY Change 144.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17333 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4948996 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3796999 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
5920213 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
4903869 USD
us-gaap Sales Revenue Net
SalesRevenueNet
10869209 USD
us-gaap Sales Revenue Net
SalesRevenueNet
8700868 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
3226366 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
2212179 USD
jrss Cost Of Medical Consumables
CostOfMedicalConsumables
1106774 USD
jrss Cost Of Medical Consumables
CostOfMedicalConsumables
817278 USD
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
1708803 USD
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
1385243 USD
us-gaap Supplies Expense
SuppliesExpense
332289 USD
us-gaap Supplies Expense
SuppliesExpense
150238 USD
us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
42825 USD
us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
21396 USD
us-gaap Utilities Costs
UtilitiesCosts
219484 USD
us-gaap Utilities Costs
UtilitiesCosts
232331 USD
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
36195 USD
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
77107 USD
us-gaap Interest Expense
InterestExpense
629314 USD
us-gaap Interest Expense
InterestExpense
691212 USD
us-gaap Professional Fees
ProfessionalFees
38313 USD
us-gaap Professional Fees
ProfessionalFees
106921 USD
us-gaap Depreciation
Depreciation
614351 USD
us-gaap Depreciation
Depreciation
497019 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7954714 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6190924 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2509944 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2894232 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2514701 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1635 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2306 USD
us-gaap Profit Loss
ProfitLoss
2892597 USD
us-gaap Profit Loss
ProfitLoss
2512395 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
867779 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
777340 USD
us-gaap Net Income Loss
NetIncomeLoss
2024818 USD
us-gaap Net Income Loss
NetIncomeLoss
1735055 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
-102987 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
66229 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
190076 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-168043 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3185660 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2278123 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
970766 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
711111 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2214894 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1567012 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.1247
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13915000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13915000 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
2914495 USD
us-gaap Interest Expense Other
InterestExpenseOther
629314 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
286081 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
360934 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13024 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
126677 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-160093 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-100126 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
412846 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-23637 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
102234 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
96809 USD
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
1781 USD
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-271 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-73300 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
36316 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1878820 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3422358 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
886542 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1726351 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2074565 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2867507 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
861407 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
1512487 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-70088 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-43524 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-7592 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-8938 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-273425 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
502389 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
352153 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
854542 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1635 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2306 USD
us-gaap Interest Paid Net
InterestPaidNet
629314 USD
us-gaap Interest Paid Net
InterestPaidNet
716980 USD
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
0 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
431060 USD
us-gaap Interest Expense Other
InterestExpenseOther
691212 USD
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
1141156 USD
CY2012Q4 jrss Joint Venture Investment Obligation To Pay Capital
JointVentureInvestmentObligationToPayCapital
5555556 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25 pure
CY2017Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3732780 USD
CY2016Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3359619 USD
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
24715 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
24119 USD
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27154465 USD
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2926357 USD
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
2221016 USD
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
2193932 USD
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
13197940 USD
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
18716945 USD
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
1104057 USD
jrss Capital Lease Financing Fees
CapitalLeaseFinancingFees
640330 USD
jrss Capital Lease Financing Fees
CapitalLeaseFinancingFees
697383 USD
CY2017Q2 us-gaap Short Term Debt Percentage Bearing Fixed Interest Rate
ShortTermDebtPercentageBearingFixedInterestRate
0.0609 pure
us-gaap Interest Expense Debt
InterestExpenseDebt
10489 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2024818 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1735055 USD
CY2017Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1153588 USD
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
0 USD
CY2016 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
0 USD
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13915000 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13915000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13915000 shares
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20263 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4757 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
380000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
76495 USD
us-gaap Proceeds From Long Term Capital Lease Obligations
ProceedsFromLongTermCapitalLeaseObligations
0 USD
us-gaap Proceeds From Long Term Capital Lease Obligations
ProceedsFromLongTermCapitalLeaseObligations
961408 USD
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
115763 USD
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
680245 USD
us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
1137189 USD
us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="center"></div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; WIDTH: 100%; FONT-SIZE: 10pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; WIDTH: 0.5in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="top" width="48"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt">C.</font></i></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt" align="justify"><i> <font style="FONT-SIZE: 10pt">Use of estimates</font></i></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities&#160;at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made; however actual results could differ from those estimates. Significant items subject to such estimates and assumptions include valuation allowances for receivables and recoverability of carrying amount and the estimated useful lives of long-lived assets. These estimates are often based on complex judgments and assumptions that management believes to be reasonable but are inherently uncertain and unpredictable.&#160;Actual results could differ from these estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; WIDTH: 100%; FONT-SIZE: 10pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; WIDTH: 0.5in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="top" width="48"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt">E.</font></i></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt" align="justify"><i> <font style="FONT-SIZE: 10pt">Concentration of Credit Risk</font></i></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk are cash, accounts receivable and other receivables arising from its normal business activities. The Company places its cash in what it believes to be credit-worthy financial institutions. The Company has a diversified customer base. The majority of sales are either cash receipt in advance or cash receipt upon delivery. For the six months ended June 30, 2017 and 2016, no customer accounted for more than <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font></font>% of net revenue. As of June 30, 2017 and December 31, 2016, 3 and 2 customers, respectively, accounted for more than <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font></font>% of net accounts receivable, respectively. For those credit sales, the Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk, establishes an allowance, if required, for uncollectible accounts and, as a consequence, believes that its accounts receivable credit risk exposure beyond such allowance is limited.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
6910 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
12609 USD
CY2017Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
6573 USD
CY2017Q2 jrss Consulting Fee
ConsultingFee
16439 USD
CY2016Q2 jrss Consulting Fee
ConsultingFee
17267 USD
CY2017Q2 jrss Capital Lease Financing Fees
CapitalLeaseFinancingFees
314513 USD
CY2016Q2 jrss Capital Lease Financing Fees
CapitalLeaseFinancingFees
353904 USD
CY2017Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
804727 USD
CY2016Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
846101 USD
CY2016Q4 jrss Prepaid Maintenance Cost
PrepaidMaintenanceCost
1451136 USD

Files In Submission

Name View Source Status
0001144204-17-042622-index-headers.html Edgar Link pending
0001144204-17-042622-index.html Edgar Link pending
0001144204-17-042622.txt Edgar Link pending
0001144204-17-042622-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
jrss-20170630.xml Edgar Link completed
jrss-20170630.xsd Edgar Link pending
jrss-20170630_cal.xml Edgar Link unprocessable
jrss-20170630_def.xml Edgar Link unprocessable
jrss-20170630_lab.xml Edgar Link unprocessable
jrss-20170630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v472921_10q.htm Edgar Link pending
v472921_ex31-1.htm Edgar Link pending
v472921_ex31-2.htm Edgar Link pending
v472921_ex32-1.htm Edgar Link pending
v472921_ex32-2.htm Edgar Link pending